Medical Devices, Pharmaceutical

Harnessing FDA 510(k) Data Potential: RFM Modeling – A New Paradigm for MedTech Growth Decisions

Leveraging Innovative Data Analytics to Empower MedTech Companies with Foresight for Strategic Growth In the fiercely competitive and rapidly evolving global medical device industry, the ability to accurately grasp market dynamics, discern competitive landscapes, and formulate forward-thinking strategies has become paramount for sustainable corporate success. Against this backdrop, a critical determinant of success lies in transforming vast amounts of data into strategically significant business intelligence. Leveraging data- and intelligence-driven insights is essential to support and guide medical device companies, startups, and investment institutions in making informed, data-driven decisions. The Sleeping Giant: Re-evaluating the Strategic Value of Public FDA 510(k) Database...

View all

Jackson Lin

Who’s Leading the Pack? Who’s Catching Up? | 2025 Q1 FDA 510(k) Clearances: Market Opportunities and Strategic Signals Revealed by Intelligence

This article doesn't aim to provide definitive answers. Instead, through actual FDA clearance data, it presents the real-time dynamics at the forefront of the MedTech market: showing who has successfully established their presence, who is quickly catching up, and where you stand. Key Insight for Decision-Making: The Value of FDA MedTech Data Precise and timely decisions are the cornerstone of success in the rapidly evolving medical device industry. If you are evaluating your next product development direction, potential market expansion regions, tracking the latest moves of your key competitors, or screening potential investment targets, the latest FDA Class II 510(k)...

了解更多

Eugene Lu

Medtronic’s Strategic Investments in Diabetes Business: A More Precise and Patient-Centric Diabetes Care Solution Could Be Expected From the Three Recent Acquisitions.

In 2001, Medtronic strategically acquired Minimed and Medical Research Group to enter the battlefield of diabetes care management. During the last two years, mergers and acquisitions have also expanded its diabetes market.   In 2018, Medtronic acquired Nutrino, a start-up company. It was aiming for Nutrino’s food database and the algorithm for predicting blood glucose after meals. Medtronic will integrate related technologies into its own diabetes products to help diabetes management. In 2019, Medtronic acquired Klue, a start-up company. Klue uses gesture sensing technology to monitor and record users’ eating behavior and give advice on eating behaviors/habits. Recently, Medtronic announced that it...

了解更多

Leo Tsou

The Race for Coronavirus Vaccine Development: Beware of Entering Into Future Patent Wars

COVID-19 is a worldwide pandemic. To solve this crisis, scientists, pharmaceutical companies, and biotech companies—such as AstraZeneca, Moderna, Pfizer, BioNTech, Novavax and J&J—are currently working on finding cures. The world’s urgent need for a vaccine has never been seen before. However, many vaccine developing companies might not notice that they are walking straight into a future patent war. This article explains why there will be a patent war in the near future and provides advice for those vaccine developing companies that are participating in or are going to participate in the race for vaccine development. The Race for COVID-19 Vaccine...

了解更多

Yolanda Huang

WISPRO Expert Corner 2020/07/17

Are M&A in Semiconductors Trending Again? Verifying M&A Business Strategies via Patent Data On July 13, 2020, Semiconductor chipmaker Analog Devices Inc (ADI) announced it would buy rival company Maxim Integrated Products (MXIM), making it the largest M&A deal in the chipmaking sector this year. Reported by Reuters, the transaction to acquire MXIM will cost ADI about 21 billion, the deal is expected to boost ADI’s market share in self-driving and 5G chips. Interviewed by Reuters, ADI’s Chief Executive Officer, Vincent Roche opined that combining the engineering teams of both companies is expected to enable the design and production of ICs...

了解更多

Leo Tsou

WISPRO Expert Corner 2020/06/12

How Does One Avoid Being Deceived by Medical Academic Scandals? WISPRO Manager Leo Tsou: Scientific Findings in the Medical Field Need Time to Accumulate, Track Records Are Not Easy to Fake. Earlier this month, two of the world’s leading medical journals—The Lancet and The New England Journal of Medicine—retracted articles related to Covid-19 studies based on data provided by the small US company, Surgisphere. Those journals retracted their articles because the data provided by Surgisphere was found to contain artificial traces, and Surgisphere refused to provide raw data to the co-authors and peer review auditors. The article published by The...

了解更多

Daniel Kuo

WISPRO Expert Corner 2020/06/09

New Video Coding Standard Released. WISPRO Analyst Daniel Kuo: Be Aware of the Licensing Conditions When Selecting From Multiple Standards According to Display Daily, the Essential Video Coding (EVC) standard led by Huawei, Qualcomm, and Samsung was officially released in April 2020. Additionally, the development of Versatile Video Coding (VVC) standards will also be completed in due course. The next generation of video coding technology is a competitive situation. The supporters, the business models, and the licensing strategies of all parties will influence whether the standard will succeed in the future. Besides VVC, EVC, and AV1—led by Google and other entities—the previous technical standards, including High-efficiency Video Coding (HEVC) and Advanced Video Coding (AVC),...

了解更多

Leo Tsou

WISPRO Expert Corner 2020/06/02

Scientists Find a Potential Treatment for COVID-19 From a SARS Survivor – Is Antibody Isolated From a Patient Patentable? Manager Leo Tsou: The Subject Matter of the Claim Is the Key. Recently, scientists reported that a monoclonal antibody code-named S309, which was first discovered from the blood sample of a SARS survivor in 2003, showed its extraordinary capability of neutralizing the COVID-19 virus in a lab. The antibody has the potential to be developed as a COVID-19 treatment, and will be applied in clinical trials in the near future. However, based on the decision of the Myriad Case by the US Supreme Court...

了解更多

Alex Chou

Market Analysis for AI in Medical Imaging Industry

The value and growth of the global medical imaging industry have attracted global investors and technical teams into artificial intelligence solutions for medical imaging. According to the Global Medical Imaging Trends research report released by ITN Online in 2017, the total number of global medical images will increase at a compound annual growth rate of 5.1% from year 2016 to 2021. In addition, Market Research Engine’s market research report also pointed out the estimated production value of medical imaging will grow from $2.2 billion in 2015 to more than $3 billion in 2021, with a compound annual growth rate of 8.0%....

了解更多
Load More

WISPRO TECHNOLOGY CONSULTING CORPORATION

WISPRO INTERNATIONAL PATENT & TRADEMARK OFFICE

Copyright © 2022 WISPRO. All Rights Reserved